Engerix-B

Engerix-B is a vaccine designed to prevent hepatitis B, a viral infection affecting the liver. It contains hepatitis B surface antigen (rDNA) and alum as an adjuvant. This vaccine is suitable for individuals at risk of hepatitis B infection.

Engerix-B is primarily used for the prevention of hepatitis B virus (HBV) infection. It is administered to individuals who are at high risk of contracting the virus, such as healthcare workers, travelers to regions with high HBV prevalence, and those with certain medical conditions. The vaccine works by stimulating the body's immune response to produce antibodies against the hepatitis B virus.

Common effects of Engerix-B may include mild soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, headache, or fatigue following vaccination. These effects are typically mild and short-lived.

Engerix-B should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to yeast, any component of the vaccine, or a previous dose of hepatitis B vaccine should inform their healthcare provider before receiving the vaccine. It is important to follow the recommended vaccination schedule for optimal protection.

Engerix-B may interact with certain medications or medical conditions. It is important to inform your healthcare provider about any ongoing treatments or health conditions before receiving the vaccine. Specific interactions with alcohol or other substances have not been widely reported, but general precautions should be taken.